Newsroom

Recent News Releases

July 16, 2019 7/16/2019 First iPSC-Derived CAR T-Cell Therapy Created by Kyoto University CiRA and Takeda Collaboration Enters Process Development Toward Clinical Testing

July 10, 2019 7/10/2019 Takeda Continues Ongoing Inclusion in the FTSE4Good Developed Index & MSCI ESG Leaders Index

July 8, 2019 7/8/2019 Takeda Unveil New Data from the PROPEL Study at ISTH 2019, Reinforcing the Potential Benefit for Personalized Prophylaxis with ADYNOVATE in Severe Hemophilia A

July 2, 2019 7/2/2019 Takeda Announces Baxalta’s Successful Consent Solicitation with Respect to Baxalta’s 3.600% Senior Notes due 2022, 4.000% Senior Notes due 2025, 5.250% Senior Notes due 2045

June 30, 2019 6/30/2019 Takeda Completes Sale of XIIDRA^® to Novartis

SEE ALL NEWS AND RELEASES >

・For legacy Shire information, click here

Featured Topics

2019 Innovators in Science Award Winners Celebrated for Regenerative Medicine Research

LEARN MORE

Takeda breaks ground on a state of the art facility in Osaka, Japan

LEARN MORE

Strengthening Takeda’s Global Reach by Sustaining Core Values

LEARN MORE

Deepening Our Commitment to Research with State-of-the-Art Facility in San Diego, California

LEARN MORE

CEO Christophe Weber on Why Takeda’s Unique Corporate Governance Structure Works

LEARN MORE

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.